index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Cells Becker BMD muscular dystrophy Epigenetics Dystrophie Musculaire de Becker BMD Dystrophie musculaire de Becker Dystrophie Musculaire de Duchenne DMD NAD+ Cell Line LncARN Dynamin 2 LKB1 Myotendinous junction Muscle Inhibitors Inbred C57BL Liver Becker muscular dystrophy Multi resolution modeling Dystrophy Muscular Dystrophy Energy Metabolism/drug effects Cultured Knockout Modificateurs de gènes Calcium Exon skipping Drp1 Mitochondrial fission Centronuclear myopathy Autophagy DMO Metabolism Molecular docking Duchenne muscular dystrophy Hear Génomique Muscle Strength Gene modifiers DMD CTNNB1 Multiresolution modeling L-Type Diseases Molecular Sequence Data Muscles/physiopathology Clinical trials Human Umbilical Vein Endothelial Cells Gene expression Allele‐specific silencing therapy MiARN Antisense oligonucleotides Dystrophin Base Sequence CaVβs MES Muscular Atrophy Inbred mdx Long QT Muscular dystrophy Dystrophine NNOS CaV subunits Animal/physiopathology Skeletal muscle Cell homeostasis Long noncoding RNA Mice Activin Receptors Animals Genomic Myogenesis Duchenne DMD dystrophy Ex-vivo Cell Biology Humans Delivery Dystrophin central domain Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Calcium Channels Male Becker muscular dystrophy BMD Muscle Biology DHPR α1S Immunoglobulin Fc Fragments/pharmacology Invivo Homeostasis Cardiomyopathie Cachexia Mdx mouse Gene Expression Regulation/drug effects Hepatocellular carcinoma Muscle development Morphogenesis LncRNA Dystrophin-EGFP Duchenne muscular dystrophy DMD Cardiomyopathy Multi exon skipping CD38 BMD